'You kill the bacteria and heal the wound at the same time': Emerging nanotech could be the future of wound healing
Researchers are developing nanomaterials that use light activation to treat stubborn infections and accelerate healing. These therapies target slow-healing lesions often found in burn victims and people with diabetes. Initial tests show promise in animal models, though human trials have not yet occurred.
What changed
New details emerged regarding the use of light-activated nanomaterials and their testing in mice and pigs.
Live updates
-
Nanotech Light-Activated Therapies Target Antibiotic-Resistant Wounds
confidence 80%Researchers are developing nanomaterials that use light activation to treat stubborn infections and accelerate healing. These therapies target slow-healing lesions often found in burn victims and people with diabetes. Initial tests show promise in animal models, though human trials have not yet occurred.
What's confirmed:
- Light-activated therapies are being developed to treat slow-healing lesions common in burn victims and diabetics.
- Certain wounds, such as diabetic ulcers and severe burns, can develop bacterial infections that resist antibiotics.
Still unconfirmed:
- Ecofriendly antibacterial nanoparticles with healing effects have been tested in a murine diabetic skin infection model.